Abstract
The aim of the study was to investigate whether polymorphisms of macrophage migration inhibitory factor (MIF) determine susceptibility to or severity of inflammatory polyarthritis (IP). Genotypes for a single-nucleotide polymorphism (MIF-173*G/C) and a tetranucleotide (CATT)n repeat mapping to the promoter region of the MIF gene were compared between UK Caucasian IP cases (n=438) and controls (n=343). Both polymorphisms were also investigated for association with features of disease activity and severity at baseline and by 5 years. The MIF-173*C allele (OR 1.7, 95% CI 1.3–2.4, P=1.8 × 10−4) and the CATT7 allele (OR 1.5, 95% CI 1.0–2.1, P=0.02) were found to be associated with increased susceptibility to IP. Furthermore, presence of the haplotype containing both associated polymorphisms was associated with a three-fold increase risk of developing IP. No association with disease severity or activity either at baseline or by 5 years was detected for either of the promoter polymorphisms studied. In conclusion, MIF is a susceptibility gene for the development of IP. The same alleles previously reported to be associated with susceptibility to juvenile idiopathic arthritis account for the increased risk. The promoter polymorphisms of MIF, investigated in this study, do not influence the severity of disease outcome by 5 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
MacGregor AJ, Snieder H, Rigby AS et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30–37.
Thomson W, Harrison B, Oilier B et al. Quantifying the exact role of HLA–DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999; 42: 757–762.
Brennan P, Harrison B, Barrett E et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ 1996; 313: 471–476.
Lolis E . Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 2001; 1: 662–668.
Mikulowska A, Metz CN, Bucala R, Holmdahl R . Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997; 158: 5514–5517.
Santos L, Hall P, Metz C, Bucala R, Morand EF . Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001; 123: 309–314.
Leech M, Metz C, Santos L et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998; 41: 910–917.
Donn RP, Shelley E, Oilier WE, Thomson W . A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782–1785.
Donn R, Alourfi Z, De Benedetti F et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402–2409.
Baugh JA, Chitnis S, Donnelly SC et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170–176.
Alourfi Z, Donn R, Ray D . Macrophage migration inhibitory factor (MIF) expression is differentially regulated by a functional interaction between two promoter polymorphisms. Rheumatology (Oxford), 2003; 42 (suppl): 6.
Onodera S, Nishihira J, Iwabuchi K et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002; 277: 7865–7874.
Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD . Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002; 41: 558–562.
Donn RP, Zeggini E, Lamb et al. Linkage and association of macrophage migration inhibitory factor (MIF) with juvenile idiopathic arthritis. Rheumatology (Oxford), 2003; 42 (suppl.) 82.
Dugowson CE, Nelson JL, Koepsell TD . Evaluation of the 1987 revised criteria for rheumatoid arthritis in a cohort of newly diagnosed female patients. Arthritis Rheum. 1990; 33: 1042–1046.
Leech M, Metz C, Bucala R, Morand EF . Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum 2000; 43: 827–833.
de Jong YP, Abadia-Molina AC, Satoskar AR et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061–1066.
Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG . In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol 2003; 170: 1274–1282.
Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ . The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33: 735–739.
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.
MacGregor AJ, Bamder S, Silman AJ . A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results from an analysis from a nationwide twin study. J Rheumatol 1994; 21: 1420–1426.
Bukhari M, Harrison B, Lunt M, Scott DG, Symmons DP, Silman AJ . Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum 2001; 44: 1248–1253.
Larsen A, Dale K, Eek M . Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Ada Radiol Diagn (Stockh) 1977; 18: 481–491.
Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ . Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002; 46: 906–912.
Curtis D, Sham PC . Model-free linkage analysis using likelihoods. Am J Hum Genet 1995; 57: 703–716.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding: Arthritis Research Campaign
Rights and permissions
About this article
Cite this article
Barton, A., Lamb, R., Symmons, D. et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 4, 487–491 (2003). https://doi.org/10.1038/sj.gene.6364014
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364014
Keywords
This article is cited by
-
The immunobiology of MIF: function, genetics and prospects for precision medicine
Nature Reviews Rheumatology (2019)
-
Influence of the MIF polymorphism −173G > C on Turkish postmenopausal women with osteoporosis
Zeitschrift für Rheumatologie (2018)
-
Macrophage migration inhibitory factor promoter polymorphisms (−794 CATT5–8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects
BMC Cardiovascular Disorders (2017)
-
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients
Digestive Diseases and Sciences (2016)
-
Variations in ncRNA gene LOC284889 and MIF-794CATT repeats are associated with malaria susceptibility in Indian populations
Malaria Journal (2013)